TAS2R14 and COVID-19: Interestingly, a recent deep sequencing study with COVID-19 patients admitted to the Intensive Care Unit shows significant alternative transcription differences in TAS2R14. Patients who died from COVID-19 showed 0.15892% splice variant versus 0.03625% in patients with COVID-19 who lived (Monaghan et al., 2021) suggesting a role for the receptor in injury.